Preclinical characterization of ARX517, a next-generation anti-PSMA antibody drug conjugate for the treatment of metastatic castration-resistant prostate cancer

被引：2
|
作者：
Skidmore, Lillian
Mills, David
Kim, Ji Young
Shastri, Prathap
Knudsen, Nick A.
Steen, Jeff
Nelson, Jay
Buechler, Ying
Tian, Feng
Zhang, Shawn
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3997
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A substudy of the VISION trial
    Kurth, Jens
    Herrmann, Ken
    Eiber, Matthias
    Rahbar, Kambiz
    Heuschkel, Martin
    Lassmann, Michael
    Jentzen, Walter
    Chicco, Daniela
    Messmann, Richard
    Sartor, A. Oliver
    Morris, Michael J.
    Krause, Bernd J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] Treatment of metastatic castration-resistant prostate cancer. Drug interaction potentials of abiraterone acetate and enzalutamide
    Lipp, H-P.
    Miller, K.
    UROLOGE, 2016, 55 (06): : 766 - 771
  • [43] A systematic literature review and indirect treatment comparison of PARP inhibitors in combination with next-generation hormonal agents in BRCA-mutated metastatic castration-resistant prostate cancer
    Shore, Neal D.
    Williams, Jack
    Clouthier, Derek L.
    Swift, Stephanie L.
    Tatman, Sophie
    Lang, Shona
    Hettle, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab Plus Doxorubicin in the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Slovin, Susan F.
    Kelly, W. Kevin
    Wilton, Andrew
    Kattan, Michael
    Myskowski, Patricia
    Mendelsohn, John
    Scher, Howard I.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (03) : E77 - E82
  • [45] Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience
    Satapathy, Swayamjeet
    Das, Chandan K.
    Aggarwal, Piyush
    Sood, Ashwani
    Parihar, Ashwin S.
    Singh, Shrawan K.
    Mittal, Bhagwant R.
    PROSTATE, 2023, 83 (02): : 169 - 178
  • [46] Preclinical characterization of ETx-22, a next-generation antibody drug conjugate (ADC) targeting nectin-4
    Azim, Hatem
    Lhospice, Florence
    Preville, Xavier
    Fares, Joanna
    Lopez, Marc
    Crompot, Emerence
    Josselin, Emmanuelle
    Castellano, Remy
    Wehbeh, Maria
    Collette, Yves
    Elands, Jack
    Olive, Daniel
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [47] Baseline PSMA PET/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients
    Kleiburg, Fleur
    de Geus-Oei, Lioe-Fee
    Spijkerman, Romy
    Noortman, Wyanne A.
    van Velden, Floris H. P.
    Manohar, Srirang
    Smit, Frits
    Toonen, Frank A. J.
    Luelmo, Saskia A. C.
    van der Hulle, Tom
    Heijmen, Linda
    EUROPEAN RADIOLOGY, 2025,
  • [48] Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Danila, Daniel C.
    Scher, Howard I.
    Szafer-Glusman, Edith
    Herkal, Amrita
    Suttmann, Rebecca
    Fleisher, Martin
    Schreiber, Nicole A.
    Curtis, Kristen
    Gilbert, Houston
    Maslyar, Daniel
    Fine, Bernard
    Firestein, Ron
    Mamounas, Michael
    Lackner, Mark R.
    Kabbarah, Omar
    CANCER RESEARCH, 2015, 75
  • [49] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [50] PRECLINICAL ACTIVITY AND SAFETY PROFILE OF JANX007, A NOVEL PSMA-TARGETING TUMORACTIVATED T CELL ENGAGER FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    DiRaimondo, Thomas
    Budimir, Natalija
    Shenhav, Simon
    Wu, Hua
    Cicchini, Vanessa
    Jocic, Renee
    Ma, Lina
    Roup, Fabrece
    Campbell, Calvin
    Caffaro, Carolina
    Aerni, Hans
    Eskiocak, Ugur
    Godfrey, Wayne
    Winter, Charles
    Nasoff, Marc
    Gibson, Neil
    Campbell, David
    Salek-Ardakani, Shahram
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1376 - A1376
12345